Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men

International Journal of STD and AIDS

Volumn 20, Issue 4, 2009, Pages 262-264

  Jong, E ^a   Van Gorp, E C M ^a   Mulder, J W ^a   Tol, A ^a   Smits, P H M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

HIV; HPV; Men; PCR; Urine

Indexed keywords

DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROL GROUP; CONTROLLED STUDY; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URINALYSIS; VIROTHERAPY; VIRUS LOAD; WART VIRUS;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; URINE; VIRAL LOAD;

EID: 66349094388     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008359     Document Type: Article

References (20)

1. Munoz N, Bosch FX, de SS, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527 (Pubitemid 36159887)
2. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32(Suppl 1):S16-24 (Pubitemid 40332585)
3. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001;184:682-690 (Pubitemid 32826418)
4. Moscicki AB, Durako SJ, Houser J, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003;17:311-320 (Pubitemid 36223255)
5. Bosch FX, Munoz N, Shah KV, Meheus A. Second International Workshop on the Epidemiology of Cervical Cancer and Human Papillomaviruses. Int J Cancer 1992;52:171-173
6. Shah KV. Human papillomaviruses and anogenital cancers. N Engl J Med 1997;337:1386-1388 (Pubitemid 27467776)
7. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320-326 (Pubitemid 28145168)
8. Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998;36:391-394 (Pubitemid 28060301)
9. Brinkman JA, Jones WE, Gaffga AM, et al. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol 2002;40:3155-3161 (Pubitemid 34977422)
10. Melchers WJ, Schift R, Stolz E, Lindeman J, Quint WG. Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol 1989;27:1711-1714 (Pubitemid 19182867)
11. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004;31:96-99 (Pubitemid 38141642)
12. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002;35:1127-1134 (Pubitemid 35239474)
13. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:415-422 (Pubitemid 27225314)
14. Kleter B, Van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517 (Pubitemid 29337270)
15. Smits PH, Bakker R, Jong E, et al. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol 2005;43:5936-5939 (Pubitemid 43100640)
16. Palefsky JM, Holly EA, Ralston ML, Da CM, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001;183:383-391 (Pubitemid 32105597)
17. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-1057 (Pubitemid 44547644)
18. Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002;40:3341-3345 (Pubitemid 34977451)
19. Aynaud O, Piron D, Barrasso R, Poveda JD. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect 1998;74:32-34 (Pubitemid 28201977)
20. Chopra KF, Tyring SK. The impact of the human immunodeficiency virus on the human papillomavirus epidemic. Arch Dermatol 1997;133:629-633 (Pubitemid 27214973)